Pharmaceutical Products
Description
99% Injectable Polypeptide Hormones Eptifibatide CAS 148031-34-9 For Antiplatelet Drugs & Acute Coronary Syndrome
Quick Details:
Eptifibatide
Sequence: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2
Cas No.: 148031-34-9
Molecular Formula: C35H49N11O9S2
Molecular Weight: 831.96
Appearance: White slightly yellwish powder
Specific Rotation[20/D]: -75.0～-95.0°(C=1,1%HAc)
Amino Acids composition: ± 10%
Peptide Purity (By HPLC): >98% by area integration
Related Substance (By HPLC): Total Impurities (%)<2.0%;Largest Single Impurity (%)< 1.0%
Water Content (Karl Fischer): <8.0%
Peptide Content(N determination): >80%
Acetate Content: <15%
IR spectrum: in accordance
Grade : Pharmaceutical Grade
Storage: Closed, below 2 ~ 8℃ preservation
Usage : Platelet glycoprotein receptor antagonist model, the third generation of antiplatelet drugs. For acute coronary syndrome (including unstable angina or non Q wave myocardial infarction) or percutaneous coronary interventional therapy (including angioplasty or atheromatous plaque excision).
Integrilin is sold in two strengths, globally: vials containing 2 mg/ml (20 mg totally) and 0.75 mg/ml (75 mg totally).
Application:
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevatio
Read More
Hongkong Yuancheng Gongchuang Technology Co., Limited
Steroid , Peptides , Pharmaceutical
Address: Flat C 4/F Civic Comm Bldg, 165-167 Woosung St Kln, Hong Kong,
Hong Kong, Hong Kong
Hong Kong, 430064
Tel: 86-18872220819
Fax: 86-27-68886696
